General Announcement::Update on intimation regarding the Orthopaedic Business

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
01-Oct-2018 23:13:05
Status
New
Announcement Sub Title
Update on intimation regarding the Orthopaedic Business
Announcement Reference
SG181001OTHR5VZX
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
01/10/2018 19:00:00
Description (Please provide a detailed description of the event in the box below)
Sub: Update on intimation regarding the Orthopaedic Business

Reference is made to the intimation made to the Stock exchanges on August 10, 2018 by the Company in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, about the approval of the Board for the transaction with True North for Orthopaedic and Pain Management Business.

We now wish to inform you that the Company has completed the formalities.

You are requested to take the same on record.

Attachments

SGX_Ortho.pdf
Total size =482K